258 related articles for article (PubMed ID: 28403462)
1. Medicaid Coverage of Smoking Cessation Counseling and Medication Is Underutilized for Pregnant Women.
Scheuermann TS; Richter KP; Jacobson LT; Shireman TI
Nicotine Tob Res; 2017 May; 19(5):656-659. PubMed ID: 28403462
[TBL] [Abstract][Full Text] [Related]
2. 'Real-world' effectiveness of smoking cessation treatments: a population study.
Kotz D; Brown J; West R
Addiction; 2014 Mar; 109(3):491-9. PubMed ID: 24372901
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
[TBL] [Abstract][Full Text] [Related]
4. Associations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study.
Ferguson SG; Brown J; Frandsen M; West R
Addiction; 2015 Mar; 110(3):513-8. PubMed ID: 25393225
[TBL] [Abstract][Full Text] [Related]
5. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Doggrell SA
Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interventions for promoting smoking cessation during pregnancy.
Coleman T; Chamberlain C; Davey MA; Cooper SE; Leonardi-Bee J
Cochrane Database Syst Rev; 2015 Dec; (12):CD010078. PubMed ID: 26690977
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese Smokers.
Yang M; Chen H; Johnson ML; Essien EJ; Peters RJ; Wu IH; Abughosh SM
Subst Use Misuse; 2015; 50(13):1628-37. PubMed ID: 26595661
[TBL] [Abstract][Full Text] [Related]
8. Characterising the use of varenicline: an analysis of the Australian dispensing claims data.
Gobarani RK; Ilomäki J; Wood S; Abramson MJ; Bonevski B; George J
Addiction; 2022 Oct; 117(10):2683-2694. PubMed ID: 35603915
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.
Hartmann-Boyce J; Stead LF; Cahill K; Lancaster T
Addiction; 2014 Sep; 109(9):1414-25. PubMed ID: 24995905
[TBL] [Abstract][Full Text] [Related]
10. Smoking Cessation Pharmacotherapy Use in Pregnancy.
Robijn AL; Tran DT; Cohen JM; Donald S; Cesta CE; Furu K; Parkin L; Pearson SA; Reutfors J; Zoega H; Zwar N; Havard A
JAMA Netw Open; 2024 Jun; 7(6):e2419245. PubMed ID: 38941092
[TBL] [Abstract][Full Text] [Related]
11. Medicaid, Private Insurance, and the Availability of Smoking Cessation Interventions in Substance Use Disorder Treatment.
Knudsen HK; Roman PM
Psychiatr Serv; 2015 Nov; 66(11):1213-20. PubMed ID: 26234332
[TBL] [Abstract][Full Text] [Related]
12. Managing smoking cessation.
Reid RD; Pritchard G; Walker K; Aitken D; Mullen KA; Pipe AL
CMAJ; 2016 Dec; 188(17-18):E484-E492. PubMed ID: 27698200
[No Abstract] [Full Text] [Related]
13. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
Lutz MA; Lovato P; Cuesta G
Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
[TBL] [Abstract][Full Text] [Related]
14. Smoking Cessation Medication Prescribing for Smokers With and Without Mental Illness.
White SA; Stone E; Murphy KA; Daumit GL; McGinty EE
Psychiatr Serv; 2023 Apr; 74(4):332-340. PubMed ID: 36349496
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis.
Smith PH; Weinberger AH; Zhang J; Emme E; Mazure CM; McKee SA
Nicotine Tob Res; 2017 Mar; 19(3):273-281. PubMed ID: 27613893
[TBL] [Abstract][Full Text] [Related]
16. Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.
Rose JE; Behm FM
Nicotine Tob Res; 2017 Aug; 19(8):999-1002. PubMed ID: 29054128
[TBL] [Abstract][Full Text] [Related]
17. Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting.
Silva AP; Scholz J; Abe TO; Pinheiro GG; Gaya PV; Pereira AC; Santos PC
BMC Cardiovasc Disord; 2016 Jan; 16():2. PubMed ID: 26728720
[TBL] [Abstract][Full Text] [Related]
18. Trends in utilization of smoking cessation agents before and after the passage of FDA boxed warning in the United States.
Shah D; Shah A; Tan X; Sambamoorthi U
Drug Alcohol Depend; 2017 Aug; 177():187-193. PubMed ID: 28605678
[TBL] [Abstract][Full Text] [Related]
19. Prescribing of smoking cessation medication in England since the introduction of varenicline.
Langley TE; Huang Y; McNeill A; Coleman T; Szatkowski L; Lewis S
Addiction; 2011 Jul; 106(7):1319-24. PubMed ID: 21395894
[TBL] [Abstract][Full Text] [Related]
20. Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
Tonstad S
J Cardiovasc Nurs; 2006; 21(6):433-6. PubMed ID: 17293731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
